"SEIZMET TRIO 0.2: Glimepiride, Metformin SR, Voglibose Benefits"

May 24, 2024

SEIZMET TRIO 0.2 

Glimepiride (2mg), Metformin SR (500mg), Voglibose (0.2mg)

Introduction:

Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.2mg) are medications commonly used in combination to manage type 2 diabetes SEIZMET TRIO 0.2. This article explores their uses, dosage, side effects, precautions, and more.

Uses:

  • Glimepiride (2mg) helps lower blood sugar levels by stimulating the pancreas to release more insulin.
  • Metformin SR (500mg) improves insulin sensitivity, reduces glucose production in the liver, and enhances glucose uptake by muscles.
  • Voglibose (0.2mg) inhibits the breakdown of carbohydrates, leading to lower postprandial blood glucose levels.

Dosage:

  • The typical starting dose of Glimepiride is 1-2mg daily, usually taken with breakfast or the first main meal of the day.
  • Metformin SR is usually taken once daily with the evening meal or as directed by a healthcare provider.
  • Voglibose is typically taken three times daily with meals to control postprandial glucose levels.

Side Effects:

  • Common side effects of Glimepiride include dizziness, headache, and low blood sugar levels (hypoglycemia).
  • Metformin SR may cause gastrointestinal issues like diarrhea and stomach upset.
  • Voglibose can lead to abdominal discomfort, flatulence, and diarrhea.

Precautions:

  • These medications should be used cautiously in patients with kidney or liver problems.
  • Regular monitoring of blood sugar levels, kidney function, and liver function is recommended during treatment.

Conclusion: The combination of Glimepiride (2mg), Metformin SR (500mg), and Voglibose (0.2mg) in SEIZMET TRIO 0.2 offers a comprehensive approach to managing type 2 diabetes. It is essential to follow prescribed dosages, monitor for potential side effects, and maintain regular medical check-ups for optimal diabetes care and treatment outcomes.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

  For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

 


 

 

 

SHARE WITH